CAREERS
Innovation starts with
human inspiration. Come to be inspired
PATIENTS
Our employees are passionate
about helping patients
CAREERS
Innovation starts with
human inspiration. Come be inspired
PATIENTS
Our employees are passionate
about helping patients
Careers
Discover morePatients
Discover moreCORPORATE
GIVING
SUSTAINABILITY AT EDWARDS
We welcome you to review our sustainability report
LEARN MORE ABOUT
AORTIC STENOSIS
at newheartvalve.com
CORPORATE
GIVING
SUSTAINABILITY AT EDWARDS
We welcome you to review our sustainability report
LEARN MORE ABOUT
AORTIC STENOSIS
at newheartvalve.com
Corporate
Giving
Learn MoreOur commitment to charitable giving and participation in philanthropic causes is one of the defining elements of Edwards Lifesciences’ culture.
About Us
Learn more
About Us
Learn more
1958
Lowell Edwards dreams of creating an artificial heart
1960
First successful mitral valve replacement using the Starr-Edwards Silastic ball valve
1961
Edwards Laboratories established in Orange County, CA
1963
Development of the Fogarty embolectomy catheter spawns Edwards’ Vascular business
1970
Development of the Swan-Ganz catheter spawns Edwards’ Critical Care business
1975
Carpentier-Edwards porcine bioprostheses launch
1981
Carpentier-Edwards PERIMOUNT pericardial bioprostheses introduced
1993
Carpentier-Edwards Physio annuloplasty ring introduced
1993
Introduction of the Vigilance monitor
2000
Edwards Lifesciences spins off from Baxter and trades on the NYSE: EW
2000
Grand opening of Haina, Dominican Republic manufacturing facility
2004
Edwards acquires Percutaneous Valve Technologies
2005
Introduction of FloTrac minimally invasive hemodynamic monitoring technology
2007
Edwards SAPIEN transcatheter heart valve introduced in Europe
2008
Grand opening of Singapore heart valve manufacturing facility
2010
Edwards SAPIEN XT transcatheter heart valve introduced in Europe
2010
Grand opening of Draper, Utah manufacturing facility
2010
EV1000 and VolumeView monitoring technologies introduced in Europe
2011
Edwards SAPIEN transcatheter heart valve introduced in the U.S.
2012
ThruPort systems for MIVS introduced worldwide
2012
EDWARDS INTUITY valve system introduced in Europe
*not available for commercial sale in the U.S.
2013
Edwards SAPIEN XT transcatheter heart valve introduced in Japan
2013
ClearSight noninvasive monitoring system approved in Europe
2014
Edwards SAPIEN 3 transcatheter heart valve introduced in Europe
2014
EDWARDS INTUITY ELITE valve system introduced in Europe
*not available for commercial sale in the U.S.
2014
ClearSight noninvasive monitoring system approved in the U.S.
2014
Edwards SAPIEN XT transcatheter heart valve introduced in the U.S.
2015
Edwards SAPIEN 3 transcatheter heart valve introduced in the U.S.
1958
Lowell Edwards dreams of creating an artificial heart
1960
First successful mitral valve replacement using the Starr-Edwards Silastic ball valve
1961
Edwards Laboratories established in Orange County, CA
1963
Development of the Fogarty embolectomy catheter spawns Edwards’ Vascular business
1970
Development of the Swan-Ganz catheter spawns Edwards’ Critical Care business
1975
Carpentier-Edwards porcine bioprostheses launch
1981
Carpentier-Edwards PERIMOUNT pericardial bioprostheses introduced
1993
Carpentier-Edwards Physio annuloplasty ring introduced
1993
Introduction of the Vigilance monitor
2000
Edwards Lifesciences spins off from Baxter and trades on the NYSE: EW
2000
Grand opening of Haina, Dominican Republic manufacturing facility
2004
Edwards acquires Percutaneous Valve Technologies
2005
Introduction of FloTrac minimally invasive hemodynamic monitoring technology
2007
Edwards SAPIEN transcatheter heart valve introduced in Europe
2008
Grand opening of Singapore heart valve manufacturing facility
2010
Edwards SAPIEN XT transcatheter heart valve introduced in Europe
2010
Grand opening of Draper, Utah manufacturing facility
2010
EV1000 and VolumeView monitoring technologies introduced in Europe
2011
Edwards SAPIEN transcatheter heart valve introduced in the U.S.
2012
ThruPort systems for MIVS introduced worldwide
2012
EDWARDS INTUITY valve system introduced in Europe
*not available for commercial sale in the U.S.
2013
Edwards SAPIEN XT transcatheter heart valve introduced in Japan
2013
ClearSight noninvasive monitoring system approved in Europe
2014
Edwards SAPIEN 3 transcatheter heart valve introduced in Europe
2014
EDWARDS INTUITY ELITE valve system introduced in Europe
*not available for commercial sale in the U.S.
2014
ClearSight noninvasive monitoring system approved in the U.S.
2014
Edwards SAPIEN XT transcatheter heart valve introduced in the U.S.
2015
Edwards SAPIEN 3 transcatheter heart valve introduced in the U.S.